| Literature DB >> 22645496 |
Milda Norkiene1, Alma Gedvilaite.
Abstract
Heterologous gene expression is dependent on multistep processes involving regulation at the level of transcription, mRNA turnover, protein translation, and posttranslational modifications. Codon bias has a significant influence on protein yields. However, sometimes it is not clear which parameter causes observed differences in heterologous gene expression as codon adaptation typically optimizes many sequence properties at once. In the current study, we evaluated the influence of codon bias on heterologous production of human papillomavirus type 16 (HPV-16) major structural protein L1 in yeast by expressing five variants of codon-modified open reading frames (OFRs) encoding HPV-16 L1 protein. Our results showed that despite the high toleration of various codons used throughout the length of the sequence of heterologously expressed genes in transformed yeast, there was a significant positive correlation between the gene's expression level and the degree of its codon bias towards the favorable codon usage. The HPV-16 L1 protein expression in yeast can be optimized by adjusting codon composition towards the most preferred codon adaptation, and this effect most probably is dependent on the improved translational elongation.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22645496 PMCID: PMC3356764 DOI: 10.1100/2012/979218
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Codon usage in HPV-16 L1-Sc, L1-Pl, L1-Ec, Li, L1-Hm, and L1-Pv ORFs.
| Amino acids | Codons | Number of the indicated codons in the ORF | ||||
|---|---|---|---|---|---|---|
| L1-Pv | L1-Ec | L1-Pl | L1-Hm | L1-Sc | ||
| Ala | GCU | 10 | 20 | 29 | 30 | |
| GCC | 6 | 4 | 30 | |||
| GCA | 14 | 1 | ||||
| GCG | 6 | |||||
|
| ||||||
| Arg | AGA | 4 | 1 | 19 | ||
| AGG | 4 | 19 | 19 | |||
| CGU | 2 | 13 | ||||
| CGC | 4 | 2 | ||||
| CGA | 4 | 1 | ||||
| CGG | 1 | 2 | ||||
|
| ||||||
| Asn | AAU | 21 | 28 | 27 | ||
| AAC | 7 | 28 | 28 | 1 | ||
|
| ||||||
| Asp | GAU | 18 | 27 | 27 | ||
| GAC | 9 | 27 | 27 | |||
|
| ||||||
| Cys | UGU | 9 | 1 | 12 | 12 | |
| UGC | 3 | 11 | 12 | |||
|
| ||||||
| Gln | CAA | 11 | 19 | 19 | 19 | |
| CAG | 8 | 19 | ||||
|
| ||||||
| Glu | GAA | 14 | 20 | 19 | 20 | |
| GAG | 6 | 1 | 20 | |||
|
| ||||||
| Gly | GGU | 15 | 32 | 35 | ||
| GGC | 9 | 2 | 35 | |||
| GGA | 8 | 1 | 35 | |||
| GGG | 3 | |||||
|
| ||||||
| His | CAU | 8 | 10 | 10 | ||
| CAC | 2 | 10 | 10 | |||
|
| ||||||
| Ile | AUU | 12 | 21 | 22 | ||
| AUC | 21 | 1 | 22 | |||
| AUA | 10 | 1 | ||||
|
| ||||||
| Lys | AAA | 27 | 32 | 34 | 34 | |
| AAG | 7 | 2 | 34 | |||
|
| ||||||
| Leu | UUA | 23 | 1 | |||
| UUG | 5 | 1 | 43 | |||
| CUU | 3 | 43 | ||||
| CUC | ||||||
| CUA | 7 | 8 | ||||
| CUG | 5 | 33 | 43 | |||
|
| ||||||
| Met | AUG | 10 | 10 | 10 | 10 | 10 |
|
| ||||||
| Phe | UUU | 23 | 1 | 24 | 24 | |
| UUC | 1 | 23 | 24 | |||
|
| ||||||
| Pro | CCU | 17 | ||||
| CCC | 5 | 37 | ||||
| CCA | 15 | 3 | 37 | 37 | ||
| CCG | 34 | |||||
|
| ||||||
| Ser | AGU | 7 | 1 | |||
| AGC | 2 | 2 | 33 | |||
| UCU | 13 | 1 | 31 | |||
| UCC | 4 | 23 | ||||
| UCA | 7 | 3 | 33 | 2 | ||
| UCG | 3 | |||||
|
| ||||||
| Thr | ACU | 14 | 2 | 41 | 41 | |
| ACC | 7 | 34 | 41 | |||
| ACA | 19 | 3 | ||||
| ACG | 1 | 2 | ||||
|
| ||||||
| Trp | UGG | 7 | 7 | 7 | 7 | 7 |
|
| ||||||
| Tyr | UAT | 15 | 22 | |||
| UAC | 7 | 22 | 22 | 22 | ||
|
| ||||||
| Val | GUU | 17 | 30 | 32 | 32 | |
| GUC | 2 | 1 | ||||
| GUA | 10 | |||||
| GUG | 3 | 1 | 32 | |||
Figure 1Analysis of HPV-16 L1 mRNA expression in transformed yeast cells by Northern blot. Total yeast RNA was isolated 4 h after induction from yeast transformants expressing five different HPV-16 L1 ORFs and control yeast cells transformed with the empty pFX7 vector. Fifteen micrograms of total RNA was loaded per lane and hybridized with L1-Pv, L1-Ec, L1-Pl, L1-Hm, and PGK1-control cDNA probes labeled with [α-33P]-dATP by random priming. The data from one representative experiment are shown. The 4 independent experiments with other randomly picked transformants in every group were performed with similar results.
Figure 2Analysis of HPV-16 L1 expression in yeast by SDS-PAGE (a) and Western blot with mouse polyclonal antibody against HPV-16 L1 protein (b). The same samples were run on each gel. In lanes: (1) crude lysate of yeast expressing ORF L1-Pv; (2) crude lysate of yeast expressing ORF L1-Ec; (3) crude lysate of yeast expressing ORF L1-Pl; (4) crude lysate of yeast expressing ORF L1-Hm; (5) crude lysate of yeast expressing ORF L1-Sc; (6) negative control sample from crude lysate of S. cerevisiae cells transformed with the empty vector pFX7; and M: prestained protein weight marker (Thermo Scientific Fermentas). Long arrow points to the band with HPV16 L1 protein. The protein band (~50 kDa) pointed with short arrow was used to determine the ratio of this protein in the lines for evaluation of loaded yeast lysates quantitative differences using the ImageQuant TL 1D gel analysis software (GE Healthcare). The ratio of ~50 kDa protein band in lines was 1.77, 1.00, 1.69, 1.74, 1.30, and 4.44 accordingly. The data from one representative experiment are shown. The expression level of L1 proteins in 10 randomly picked transformants in every group was alike.